Q8EUR6 AF NFT

Alanine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeig7mee6ps22r34peeqqdgn7hpg7udp2vd2u73qbr3tznvuvyjqsvy/metadata.json
IPFS of structure file: 
bafybeiehy4rm5ksimqvnjefhwyyccgrhssac3tk2ar4q342rik3mg3sgx4/AF-Q8EUR6-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x969230c804781056B36799D8DA2d131A56102425
First NFT owner address (bech32): 
genesis1j6frpjqy0qg9dvm8n8vd5tgnrftpqfp9tamana
Current NFT ID #443222 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
443222
Accession (UniProt):
Q8EUR6
Name::
Alanine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
MYCOPLASMA PENETRANS (STRAIN HF-2)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8EUR6 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8EUR6|SYA_MYCPE Alanine--tRNA ligase OS=Mycoplasma penetrans (strain HF-2) OX=272633 GN=alaS PE=3 SV=1 MSKKLTTNEIRKLWLDFFKSKNHTEVESKSLIPKNDDSLLWINSGVATLKTFFSGKENPPSKRLTNSQRCLRTNDIENVGLTSRHHTFFEMLGNFSIGDYFRKEAIEFGAELVFKVFKLDPKKIYITVYEEDQESFDLWVKNGAIKSHILKCDKSRNFWEIGSGPCGPCTEIYYDRGEKYDFQKLGEKLFFEDIENDRYIEIWNIVFSEFNNDGKNNYTKLARQNIDTGAGLERLACILQDVPTNYDTDAFVNVRSVIEKYSNKKYDNNLYFESKKDSEKVFINKCFSVIIDHFKAVIFAISDGALPSNKDRGYILRKLLRRSFLYLNYLKVSFENSKEIINTIISNNETYYPYLKENLNNVINTIKLEYDLYCESINNSFKKLNELLNKKLLDASDLFNLVTTYGFPIEIVQSLQELLTQSKDAKNLKLAEDIINSINPSDKKISISKLKIEFDEFEKLFDEHRLIANANASVKGMENQNEELLNLPTLDSSFDYEIESVKNSKVLKIFDENWKPVEEIKNKDCWVILDKTCFFATTGGQEHDTGKINKFDVVDVIKSPQGYHLHKVVKGTFKIGEKVDGQINSFDRNIIRKQHSSEHLMHSALKRVVSPTIKQEGAFKSIEKITLDFSFNRKLTYKEILGVEKEVKRIIATKNPTQVLMKTLDEAKEMGAIGYFEQVYKKISGKLRVLYLCPESIEICGGTHVYNTGDIEDFMVTGLTSKGSGSWRIEAVSSNYLVDKFKNNVIKKAIDDFNNYFKKYKELNIKDDEVEKYKKTDINSIHYLELKEINEILKNKINTLVIRKEKENLSKESNEIKNKFTEVKESTKLFLLKDIDRKLLFNSLVLAINEAKSTVFLVINEVDGVIQYVLCSNESFAKNNNLDFNLYAKDLNAKLGGKGGGRSYLVQGTILKIDEKELNKILDTINAKLK